Order Article Reprints

Al-Wahaibi LH, Hisham M, Abou-Zied HA, Hassan HA, Youssif BGM, Bräse S, Hayallah AM, Abdel-Aziz M. Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF^V600E: Design, Synthesis, and Antiproliferative Activity. Pharmaceuticals. 2023; 16(11):1522. https://doi.org/10.3390/ph16111522

Al-Wahaibi, Lamya H., Mohamed Hisham, Hesham A. Abou-Zied, Heba A. Hassan, Bahaa G. M. Youssif, Stefan Bräse, Alaa M. Hayallah, and Mohamed Abdel-Aziz. 2023. "Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF^V600E: Design, Synthesis, and Antiproliferative Activity" Pharmaceuticals 16, no. 11: 1522. https://doi.org/10.3390/ph16111522

Al-Wahaibi, L. H., Hisham, M., Abou-Zied, H. A., Hassan, H. A., Youssif, B. G. M., Bräse, S., Hayallah, A. M., & Abdel-Aziz, M. (2023). Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF^V600E: Design, Synthesis, and Antiproliferative Activity. Pharmaceuticals, 16(11), 1522. https://doi.org/10.3390/ph16111522